{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:52:33Z","timestamp":1761540753242},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ijrobp.2006.09.010","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T16:42:40Z","timestamp":1169484160000},"page":"342-346","source":"Crossref","is-referenced-by-count":21,"title":["Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation"],"prefix":"10.1016","volume":"67","author":[{"given":"Peter","family":"Orio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Herstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mitsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Sutlief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.09.010_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0360-3016(01)01473-0","article-title":"A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy","volume":"50","author":"Potters","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0360-3016(03)01448-2","article-title":"I-125 versus Pd-103 for low risk prostate cancer: Preliminary biochemical outcomes from a prospective randomized multicenter trial","volume":"57","author":"Wallner","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib3","first-page":"175","article-title":"Treatment margins predict biochemical outcomes after prostate brachytherapy","volume":"10","author":"Choi","year":"2004","journal-title":"Cancer J (Scientific Am)"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.brachy.2005.09.001","article-title":"Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90?","volume":"4","author":"Papagikos","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0090-4295(99)00458-6","article-title":"Extent of extracapsular extension in localized prostate cancer","volume":"55","author":"Sohayda","year":"2000","journal-title":"Urol"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib7","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2630::AID-CNCR20>3.3.CO;2-C","article-title":"The radial distance of extraprostatic extension of prostate carcinoma: Implications for prostate brachytherapy","volume":"85","author":"Davis","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.coc.0000091297.21810.fa","article-title":"Extracapsular dose distribution following permanent prostate brachytherapy","volume":"26","author":"Merrick","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0360-3016(01)02652-9","article-title":"Can extraprostatic extension be treated by prostate brachytherapy?","volume":"51","author":"Butzbach","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1538-4721(02)00017-X","article-title":"What is the optimal dose for 125-I prostate implant?","volume":"1","author":"Stock","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2005.03.019","article-title":"20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: Early biochemical outcomes from a prospective randomized multi-center trial","volume":"75","author":"Wallner","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib12","first-page":"78","article-title":"Modified uniform seed loading for prostate brachytherapy: Rationale, design, and evaluation","volume":"6","author":"Merrick","year":"2000","journal-title":"Techniques Urol"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib13","first-page":"1493","article-title":"Follow-up care for cancer: Making the benefits equal the cost","volume":"14","author":"Schwartz","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0360-3016(99)00017-6","article-title":"Follow-up costs after external beam irradiation for low risk prostate cancer","volume":"44","author":"Tralins","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.09.010_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606029634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606029634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T19:50:39Z","timestamp":1547063439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606029634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0360301606029634"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.09.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}